Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Rescigno P, Maruzzo M, Rebuzzi SE, Murianni V, Cinausero M, Lipari H, Fratino L, Gamba T, De Giorgi U, Caffo O, Bimbatti D, Dri A, Mosca A, Giunta EF, Ermacora P, Vignani F, Msaki A, Bonifacio B, Lombardo V, Conteduca V, Basso U, Fornarini G, Banna GL. Rescigno P, et al. Among authors: giunta ef. Oncologist. 2022 Dec 9;27(12):e949-e956. doi: 10.1093/oncolo/oyac147. Oncologist. 2022. PMID: 35920559 Free PMC article.
Systemic therapy for pre-treated malignant mesothelioma: A systematic review, meta-analysis and network meta-analysis of randomised controlled trials.
Banna GL, Signori A, Curioni-Fontecedro A, Cortellini A, Ponzano M, Giunta EF, Rebuzzi SE, Chan S, Gebbia V, van Eeden R, Addeo A, Ottensmeier C. Banna GL, et al. Among authors: giunta ef. Eur J Cancer. 2022 May;166:287-299. doi: 10.1016/j.ejca.2022.02.030. Epub 2022 Mar 28. Eur J Cancer. 2022. PMID: 35358809 Review.
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network.
Banna GL, Basso U, Giunta EF, Fratino L, Rebuzzi SE, Buti S, Maruzzo M, De Giorgi U, Murianni V, Cinausero M, Lipari H, Gamba T, Caffo O, Bimbatti D, Dri A, Mosca A, Ermacora P, Vignani F, Msaki A, Bonifacio B, Lombardo V, Conteduca V, Fornarini G, Rescigno P. Banna GL, et al. Among authors: giunta ef. Curr Oncol. 2022 Oct 14;29(10):7745-7753. doi: 10.3390/curroncol29100612. Curr Oncol. 2022. PMID: 36290889 Free PMC article.
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score.
Fornarini G, Rebuzzi SE, Buti S, Rescigno P, Merseburger A, Sternberg CN, de Giorgi U, Basso U, Maruzzo M, Giannatempo P, Ponzano M, Giunta EF, Catalano F, Murianni V, Damassi A, Cremante M, Gandini A, Puglisi S, Llaja Obispo MA, Signori A, Banna GL. Fornarini G, et al. Among authors: giunta ef. Minerva Urol Nephrol. 2023 Jun;75(3):308-318. doi: 10.23736/S2724-6051.22.05135-7. Epub 2022 Dec 13. Minerva Urol Nephrol. 2023. PMID: 36511379 Free article. Clinical Trial.
56 results